Deletions of sequences centromeric to the p-arm breakpoint 16q22, a gene encoding for the ␤ subunit (CBFB) of the core have been described in a subset of patients with inv(16) and binding transcription factor (CBF) whose DNA target acute myeloid leukemia (AML) and reported to be associated sequences have been identified in the promoter-enhancer with a relatively good prognosis. We have investigated 16 p regions of hematopoietic specific genes. here. increased marrow eosinophils and a structurally abnormal chromosome 16. Soon after, a pericentric inversion of chromosome 16, inv(16)(p13q22), was described in 18 patients Patients, materials and methods who had M4 leukemia and morphologically abnormal eosinophils with irregular, basophilic-staining granules and distinct Patients cytochemical properties.
To assess further the incidence of the 16 p deletions and to improve the understanding of their prognostic significance, we Introduction studied 15 patients with AML and inv(16) or t(16;16) by fluorescence in situ hybridization (FISH) using the zit14 cosmid In 1983, Arthur and Bloomfield 1,2 reported five patients with as a probe. Clinical, cytogenetic and FISH data are reported acute myeloid leukemia (AML) of myelomonocytic type (M4), here. increased marrow eosinophils and a structurally abnormal chromosome 16. Soon after, a pericentric inversion of chromosome 16, inv(16)(p13q22), was described in 18 patients
Patients, materials and methods who had M4 leukemia and morphologically abnormal eosinophils with irregular, basophilic-staining granules and distinct Patients cytochemical properties. 3, 4 A related chromosome abnormality, t(16;16)(p13;q22), was reported in one patient with Fifteen patients with either inv(16) or t(16;16) were diagnosed similar characteristics. 5 Further studies have suggested that at the divisions of hematology of the University Hospitals of these two abnormalities were uniquely associated with M4
Zü rich (four patients), Basel (three), Bern (three), Lausanne and abnormal eosinophils and the correlation between the (two) and of the Canton Hospitals of Sankt-Gallen (two) and karyotype and morphology has led to a subcategory in the Aarau (one) between 1992 and 1995 (Table 1) . Each patient FAB classification, namely M4Eo. 6 However, both rearrangewas assigned a unique patient number for this and previous ments have been reported in other types of myeloid dispublications. [19] [20] [21] Additionally, 10 patients with AML (nine) or orders. 7, 8 In most studies, the presence of inv(16)/t(16;16) has acute lymphoblastic leukemia (ALL) (one) and normal karyobeen associated with a high cure rate with standard chemotypes or aberrations other than inv(16) or t(16;16) were investitherapy and a relatively favorable prognosis. [9] [10] [11] [12] [13] gated by FISH and served as controls. Informed consent was Inv(16) and t(16;16) have been shown to involve, on 16p13, obtained from each patient. a smooth muscle myosin heavy chain gene (MYH11) and, on
The diagnosis and classification of patients were based on morphologic and cytochemical examination of peripheral blood (PB) films, bone marrow (BM) aspirate and biopsy speci- 
Conventional cytogenetics
4 × SSC/0.05% Tween 20 for 3 min at room temperature (RT). After a preincubation in WB/5% non-fat dry milk (NFDM) at Chromosomes were prepared from PB or BM mononuclear RT for 10 min, slides were washed twice 5 min each in WB. cells and stained in G bands as described. 21, 25, 26 The number Biotin-labeled probes were detected after an incubation with of metaphases analyzed fully varied between 10 and 31 6 g/ml fluorescein isothiocyanate (FITC)-avidin (DCS, according to material available.
Vector, Burlingame, CA, USA) and an amplification with 5.5 g/ml biotinylated goat anti-avidin (Vector) followed by an incubation with FITC-avidin. 28 All reagents were diluted in FISH 4 × SSC/5% NFDM. Each incubation was performed in a moist chamber at 37°C for 30 min and followed by three washes of Slides were prepared from methanol/acetic acid fixed cell pel-5 min in WB. For dual-color experiments, signal revelation lets, fresh or stored at −20°C for up to 3 years. To detect was performed as described by Dauwerse et al, 29 except that deletions proximal of the p-arm breakpoint, one-color FISH FITC-avidin was used for detecting biotin-labeled probes and was performed on metaphase chromosomes with the pHuR 10 g/ml sheep anti-mouse Cy3 (Sigma, Buchs, Switzerland) 195 probe specific for the heterochromatic region of chromofor detecting mouse anti-DIG. DNA was counterstained with some 16 27 and the cosmid probe zit14. 15 To confirm results DAPI or propidium iodide and slides were mounted with an obtained in mosaic patients, the zit18 cosmid probe was used anti-fade solution (Vectashield; Vector). in addition to the pHuR 195 and zit14 probes in dual-color Hybridization signals were defined as follows. Either one or FISH. Both zit14 and zit18 probes, each spanning 40 kb, overtwo spots on the same chromosome were considered as one lap and are specific for sequences located in the deletion signal. As a consequence, metaphases with two spots on both region, 50 kb centromeric to the 16 p-arm breakpoint. Zit14 chromosomes 16 (2/2), two spots on one chromosome 16 and hybridizes to sequences slightly proximal to zit18 target one spot on the other (2/1), or one spot on both chromosomes sequences. Probes were labeled by nick-translation with 16 (1/1) were considered as harboring two signals. Metabiotin-16-dUTP (pHuR 195 and zit14 probes) or digoxygenin phases with two or one spot(s) on one chromosome 16 only (DIG)-11-dUTP (zit18 probe). Slides were denatured at 80°C (2/0 and 1/0 respectively) were considered as presenting in formamide 70%/2 × SSC for 5 min, dehydrated in ice-cold one signal. ethanol and air-dried. pHuR 195 (4 ng/l) and cosmid probes Hybridization signals were scored by at least two observers (20 ng/l) including 50 × human Cot 1 DNA were dissolved on a Zeiss Axioplan fluorescence microscope (Zeiss, Zü rich, in 50% formamide/2 × SSC/10% dextran sulfate, denatured at Switzerland) equipped with FITC and rhodamine filters, as 80°C for 5 min. DNA was allowed to reanneal at 37°C for well as with double (FITC/rhodamine) and triple 10 min and 15 l hybridization mixture was applied under a (FITC/rhodamine/DAPI) band pass filters. Photographs were 22 × 26 mm coverslip. After overnight hybridization at 37°C taken with a Kodak Ektachrome 320T film (Kodak, in a moist chamber, slides were washed in 50%
Lausanne, Switzerland). formamide/2 × SSC at 42°C, then in 1 × SSC at 60°C three times 5 min each and in the washing buffer (WB)
Statistical analysis Conventional cytogenetics
Thirteen patients presented with inv(16)(p13q22) and two with Continuous variables were compared using the non-parametric Wilcoxon rank-sum test. Comparisons of counts were t(16;16)(p13;q22) ( 
FISH

Results
Based on zit14 results, three distinct groups were observed among the inv(16)/t(16;16) patients (Figures 2 and 3 ; Tables 1 Patients' characteristics and clinical features and 2). In the first group (five patients), the proportion of metaphases with one signal ranged from 88.2 to 96.2% (mean Study patients were five women and 10 men (Table 1) . Their age ranged from 14 to 67 years. Median age was 36 years. At 92.4%) and patients were considered as deletion patients; the 3.4% metaphases with signals on both chromosomes 16 are diagnosis, 10 patients were categorized as M4Eo. Two additional patients had the features of M4. Other FAB categorprobably due to the presence of some normal metaphases as demonstrated by conventional cytogenetics. In the second ies observed included one patient with M5 and one patient with M2Eo. One patient, a 14-year-old male, had an AML of group (seven patients), the proportion of metaphases with signals on both chromosome 16 ranged from 90.5 to 100% probable M1 type secondary to an early B CD10
+ ALL which occurred 2 years after a T cell ALL diagnosed in 1988; at the (mean 94.7%); as this proportion is similar to that observed in the control group, patients were considered as non-deletion time of ALL, this patient did not reveal any evidence of inv(16). Patients will be described in detail elsewhere patients (Table 2 ). Case 7 was included in this group as two signals were observed in all three metaphases available. In the (Jotterand et al, manuscript in preparation). Median overall survival of the whole group has not been reached. Survival curves according to the presence/absence of the deletions were not significantly different (P = 0.17) (Figure 1 ). Median survival was 13.4 months in the seven nondeletion patients (four deceased patients); it was not reached in the five deletion patients (one deceased patient) and in the three mosaic cases (no deceased patient).
Figure 2
Schematic representation of p-arm and q-arm breakpoints, probes localization (zit14 and pHuR 195) and deletion region in inv(16), inv(16)/deletion and t(16;16), t(16;16)/deletion situations Figure 1 Kaplan-Meier survival curves in 15 inv(16)/t(16:16) patients.
(drawings are not to scale). patients were considered as mosaic patients. In all inv(16) deletion and deletion patients, more than 50% metaphases do not present any spot loss (mean values are equal to 58.3, 61.6 metaphases with a single signal, the signal was localized on the normal chromosome 16, as assessed by pHuR195 localizand 71.0%, respectively). In these patients, the proportion of metaphases with one spot loss (2/1 or 1/0) amount to 35.4, ation with regard to arm ratio. One mosaic patient (case 13) was studied in complete remission; a signal was present on 25.2 and 21.4%, respectively, those of metaphases with two spots loss represent 6.3, 12.5 and 4.1%. In control and nonboth chromosomes 16 in all metaphases analyzed.
Spot loss was evaluated in each group of patients and the deletion patients, metaphases with 2/0 (1.6% and 4.6%) are less frequent than metaphases with 1/1 (4.7% and 7.9%). The proportion of metaphases with 2/1, 1/1, 2/0, 1/0 and 0/0 were compared to those of metaphases with optimal hybridization situation is reversed in the mosaic group, where metaphases with 2/0 (21.3%) occur much more frequently than those with (either 2/2 in control and non-deletion or 2/0 in deletion patients) ( Table 2) . Results indicate that, in control, non-1/1 (10.6%). In mosaic patients, dual-color FISH with zit18 and zit14 To our knowledge, one case of inv(16) with a 16 p deletion mosaicism has been reported. 16 Subsequently however, this cosmids was performed on the slides used for zit14 hybridization assessment. In all metaphases available, the presence or case was considered as non-deleted based on additional molecular data. 17 In the other studies, the number of metaphases absence of zit18 signals correlated with that of zit14 signals (data not shown).
observed in each case and the distribution of FISH signals were not reported in detail; therefore, possible mosaic cases may have been considered as non-deleted when only a few metaphases were available.
Discussion
Fourteen of the 15 patients reported here have been studied by RT-PCR. 19 ,20 CBFB-MYH11 transcript type A (nomenWe have investigated 16 p deletions in 13 patients with inv(16) and two patients with t(16;16). Seven patients (47%) clature after Liu et al 8 ) was found in 12 cases (86%), transcript type E in two (14%) (cases 5 and 7). The presence of the showed no evidence of a deletion, whereas five patients (33%) presented 16 p deletions. The presence of the deletion was deletion in a patient with transcript type E indicates that the p-arm deletion is not restricted to CBFB-MYH11 transcript confirmed by Southern blot analysis with a MYH11 6.9 kb BamHI probe in three patients. 20 Our rate of deletion patients type A and suggests that it can be associated with other CBFB-MYH11 fusion types as well. (33%) is close or superior to those in other reports. [16] [17] [18] This finding provides further evidence of the relatively frequent Deletions in 16 p have been reported to be associated with improved survival. 16, 17 As the deleted region was shown to occurrence of this event in inv(16) patients and to the presence of some degree of genomic instability in this region preinclude the promoter and the 5Ј part of the MRP gene located 150 kb proximal to the p-arm breakpoint, Kuss et al suggested disposing to such molecular rearrangements. 18 Remarkably, two inv(16) and one t(16;16) patients showed that MRP hemizygosity may be relevant in determining the outcome of inv(16) AML patients. Although MRP status was a mosaic pattern suggesting the existence of two distinct leukemic cell populations, one with the deletion and one withnot assessed specifically, part of the MRP gene was supposed to be codeleted in our deletion patients and these patients out. It could be argued that, in these cases, the presence of one and two signals in respectively 30 and 70% of metawere compared with non-deleted and mosaic ones in terms of survival. No significant difference could be demonstrated; phases (mean values), may be due to an admixture of normal and abnormal cells. This seems unlikely according to the the result was unaltered when mosaic patients were grouped with deletion or with non-deletion ones. This finding does not results of conventional cytogenetics (100% abnormal metaphases in two patients and 92% in the third one whatever the corroborate the formally reported positive correlation between deletion and improved prognosis. However, although in culture condition) which suggest that the metaphases with two signals do not all represent normal cells. A second argument accordance with other observations, 18 our data have to be considered with caution as larger numbers of patients have to views the presence of 30% metaphases with a single signal as reflecting defective probe hybridization in these cases. There be longitudinally studied to draw any definitive conclusion regarding prognosis. Moreover, multidrug resistance is a comare several reasons for not supporting this assumption, although it cannot be excluded. In control patients, more than plex and multifactorial phenomenon that involves different mechanisms and several distinct genes such as MRP and 96% metaphases present a double signal. Experiment variability in the hybridization yield can be ruled out as each MDR1. 30 If the MRP gene is expected to play a role in the clinical response to chemotherapy, follow-up studies should analysis relied on several slides, all hybridized in separate assays. Defective hybridization is expected to generate a be performed not only at the DNA level but also at the mRNA and protein levels before any definitive statements concerning decrease in the proportion of metaphases with 2/2 (control and non-deletion patients) or 2/0 (deletion patients) and an its role in leukemic drug resistance can be made. Our study reinforces the usefulness of FISH for assessing increase in metaphases with spot loss. To characterize better mosaic patients and to test if defective hybridization may submicroscopic rearrangements of possible diagnostic and prognostic significance that escape conventional cytogenetics account for the presence of more than 25% metaphases with a single signal in these cases, the distribution of fluorescent due to their small size. While molecular techniques such as Southern blotting or microsatellite marker assessment may spots was analyzed in detail. Whereas the proportion of metaphases with three spots (2/1) is similar to those with 1 spot allow detection of the presence of the deletion in inv(16)/t(16;16) patients, metaphase FISH with appropriate loss (2/1 or 1/0) in all other groups, the proportion of metaphases with two spots loss (2/0 or 1/1) is much higher and the probes has the advantage of being enumerative and quantitative. Due to the existence of mosaic cases, the FISH approach reduction of the number of 2/2 metaphases correlates with a specific increase in 2/0 metaphases without any significant requires the observation of possibly a large number of metaphases for quantitative values to be significant. increase in the proportion of 1/1 metaphases. Moreover, in all inv(16) metaphases with a single signal, the signal was recognized in the normal chromosome 16. The use of the zit18 probe in addition to zit14 (dual-color FISH) in a number of Acknowledgements metaphases from mosaic patients with two or one zit14 signal(s) did not reveal any discrepancy between zit14 and
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